1. Home
  2. PCRX vs DEA Comparison

PCRX vs DEA Comparison

Compare PCRX & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.05

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Easterly Government Properties Inc.

DEA

Easterly Government Properties Inc.

HOLD

Current Price

$23.64

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
DEA
Founded
2006
2011
Country
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
DEA
Price
$23.05
$23.64
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$35.33
$24.99
AVG Volume (30 Days)
775.3K
399.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
7.49%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.21
$9.69
Revenue Next Year
$8.26
$7.10
P/E Ratio
$48.25
$80.77
Revenue Growth
N/A
N/A
52 Week Low
$18.80
$19.33
52 Week High
$27.64
$29.49

Technical Indicators

Market Signals
Indicator
PCRX
DEA
Relative Strength Index (RSI) 58.70 53.39
Support Level $20.88 $23.49
Resistance Level $21.60 $24.15
Average True Range (ATR) 0.80 0.54
MACD 0.39 -0.05
Stochastic Oscillator 93.52 53.10

Price Performance

Historical Comparison
PCRX
DEA

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.

Share on Social Networks: